Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 40.9B | 35.6B | 32.9B | 30.9B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 10.7B | 9.8B | 5.6B | 6.2B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 10.4B | 10.0B | 9.4B | 8.6B |
| Tax provision | 3.8B | 3.6B | 3.4B | 3.1B |
| Net income | 6.7B | 6.4B | 6.1B | 5.6B |
| Basic EPS | — | 0.5 | 0.5 | 0.5 |
| Diluted EPS | — | 0.5 | 0.5 | 0.5 |
| Basic average shares | — | 11.9B | 11.9B | 12.3B |
| Diluted average shares | — | 11.9B | 11.9B | 12.3B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |